Market Research Logo

Grass Pollen Allergy - Pipeline Review, H2 2015

Grass Pollen Allergy - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Grass Pollen Allergy - Pipeline Review, H2 2015’, provides an overview of the Grass Pollen Allergy’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Grass Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Grass Pollen Allergy and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Grass Pollen Allergy
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Grass Pollen Allergy and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Grass Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Grass Pollen Allergy pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Grass Pollen Allergy
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Grass Pollen Allergy pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Grass Pollen Allergy Overview
Therapeutics Development
Pipeline Products for Grass Pollen Allergy - Overview
Pipeline Products for Grass Pollen Allergy - Comparative Analysis
Grass Pollen Allergy - Therapeutics under Development by Companies
Grass Pollen Allergy - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Grass Pollen Allergy - Products under Development by Companies
Grass Pollen Allergy - Companies Involved in Therapeutics Development
ALK-Abello A/S
Allergy Therapeutics Plc
Anergis SA
Biomay AG
BioTech Tools s.a.
Circassia Pharmaceuticals Plc
HAL Allergy BV
Laboratorios LETI S.L.
Roxall Medizin GmbH
Shionogi & Co., Ltd.
Grass Pollen Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AllerG - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allergen Extract for Grass Pollen Allergy, Asthma and Allergic Rhino-Conjunctivitis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allergen for Seasonal Grass Pollen Induced Allergic Rhinitis and Rhino-Conjunctivitis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BM-32 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
clustoid wiesenlieschgras - Drug Profile
Product Description
Mechanism of Action
R&D Progress
gp-ASIT - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism of Action
R&D Progress
S-555739 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Timothy Grass Pollen Allergen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Asthma, Grass Pollen Allergy and Allergic Rhino-Conjunctivitis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Grass Pollen Allergy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grass Pollen Allergy - Recent Pipeline Updates
Grass Pollen Allergy - Dormant Projects
Grass Pollen Allergy - Product Development Milestones
Featured News & Press Releases
Jun 03, 2015: Positive phase IIb data on BM32, Biomay's innovative grass pollen allergy vaccine will be reported in hot topic session at major international scientific conference.
Jan 28, 2015: Biomay reports positive Phase IIb data with the innovative 3rd generation grass pollen allergy vaccine BM32
Apr 14, 2014: ALK announces FDA approval for Merck's grass sublingual allergy immunotherapy tablet GRASTEK
Feb 18, 2014: Health Canada approves submission of CTA to progress ultra-short course Pollinex Quattro Grass efficacy study
Feb 03, 2014: Merck Announces Canadian Approval of GRASTEK (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet)
Dec 16, 2013: Biomay AG successfully completes interim analysis of phase IIb study with the innovative 3rd generation grass pollen allergy vaccine BM32
Dec 12, 2013: FDA Advisory Committee meeting unanimously recommends approval of GRASTEK
Dec 10, 2013: ALK announces posting of briefing documents for FDA Advisory Committee meeting on the grass sublingual AIT tablet
Dec 06, 2013: Ethical committee of the University of Leuven approves a follow-up of the Phase IIa clinical study BTT006 to confirm a 2 years lasting immunological impact of 5 injections of gp-ASIT+TM
Nov 18, 2013: Update on Biotech Tools Phase IIa clinical study in the grass pollen allergy therapy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Grass Pollen Allergy, H2 2015
Number of Products under Development for Grass Pollen Allergy - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Grass Pollen Allergy - Pipeline by ALK-Abello A/S, H2 2015
Grass Pollen Allergy - Pipeline by Allergy Therapeutics Plc, H2 2015
Grass Pollen Allergy - Pipeline by Anergis SA, H2 2015
Grass Pollen Allergy - Pipeline by Biomay AG, H2 2015
Grass Pollen Allergy - Pipeline by BioTech Tools s.a., H2 2015
Grass Pollen Allergy - Pipeline by Circassia Pharmaceuticals Plc, H2 2015
Grass Pollen Allergy - Pipeline by HAL Allergy BV, H2 2015
Grass Pollen Allergy - Pipeline by Laboratorios LETI S.L., H2 2015
Grass Pollen Allergy - Pipeline by Roxall Medizin GmbH, H2 2015
Grass Pollen Allergy - Pipeline by Shionogi & Co., Ltd., H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Grass Pollen Allergy Therapeutics - Recent Pipeline Updates, H2 2015
Grass Pollen Allergy - Dormant Projects, H2 2015
List of Figures
Number of Products under Development for Grass Pollen Allergy, H2 2015
Number of Products under Development for Grass Pollen Allergy - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report